Capex surge signals durable AI demand, but TSMC's valuation leaves little room for error

What happened

TSMC plans to spend $60-64 billion on new factories and equipment this year, with management expecting spending through 2028 to be significantly higher than the previous three years, reinforcing its commitment to advanced-node and packaging capacity. The company's Q2 2026 results showed revenue up 36% YoY and gross margin at 67.7%, yet management also highlighted overseas-fab dilution and the fixed-cost burden of elevated capex. The stock at $428.9 already reflects strong AI demand, trading at 28.6x earnings and 22.5x EV/EBITDA, and the market narrative is crowded with consensus viewing TSMC as the cleanest play on multi-year AI infrastructure buildout. Our WAIT rating remains intact because the risks of offshore margin compression, export-control friction, and potential utilization gaps if hyperscaler capex softens outweigh the upside from confirmed near-term spending. While the long-term moat is undeniable, buying today offers insufficient edge; a pullback toward $390 or clear evidence of margin stability above 67% through 2027 would create a better risk-reward.

Implication

The elevated capex is a double-edged sword: it strengthens TSMC's competitive lead but pressures near-term free cash flow and introduces execution risk if demand timing slips. Hyperscaler capex guidance remains robust into 2027, but TSMC's customer concentration means any delay by one or two key players could quickly reduce leading-edge utilization. Overseas fabs in Arizona, Kumamoto, and Dresden dilute margins and their return is largely back-loaded, so investors should watch for any slippage in the 2H27 Arizona fab 2 ramp. Export-control risks, including the annual Nanjing license renewal and possible restrictions on advanced-node shipments, could disrupt order flow and are not fully priced in. Therefore, the prudent strategy is to wait for either a more attractive entry price or concrete evidence that margin and utilization can absorb the spending surge without compressing returns.

Thesis delta

The new article confirms management's intention to sustain elevated capex through 2028, but this was already incorporated in our master report following the Q2 2026 capex raise. The investment thesis remains unchanged: TSMC is a dominant foundry with strong AI demand, but the current stock price offers no margin of safety, and we maintain a WAIT rating. No shift is warranted because the article does not alter our bear case risks or the base, bull, or bear scenario probabilities.